Trade, TRIPS, and pharmaceuticals
- 22 January 2009
- journal article
- review article
- Published by Elsevier BV in The Lancet
- Vol. 373 (9664), 684-691
- https://doi.org/10.1016/s0140-6736(08)61779-1
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Trade in health-related servicesThe Lancet, 2009
- Closing the Affordability Gap for Drugs in Low-Income CountriesNew England Journal of Medicine, 2007
- Evaluating Drug Prices, Availability, Affordability, and Price Components: Implications for Access to Drugs in MalaysiaPLoS Medicine, 2007
- TRIPs and Public Health: The Doha Declaration and AfricaDevelopment Policy Review, 2007
- TRIPS, the Doha declaration and paragraph 6 decision: what are the remaining steps for protecting access to medicines?Globalization and Health, 2007
- Managing the effect of TRIPs on availability of priority vaccinesPublished by WHO Press ,2006
- Implications of bilateral free trade agreements on access to medicinesPublished by WHO Press ,2006
- Compulsory licences: recent experiences in developing countriesInternational Journal of Intellectual Property Management, 2006
- Asian Perspectives on Post‐Trips Issues in Intellectual PropertyThe Journal of World Intellectual Property, 2005
- Trips, Patents, Technology Transfer, Foreign Direct Investment and the Pharmaceutical industry in MalaysiaThe Journal of World Intellectual Property, 2001